GENE ONLINE|News &
Opinion
Blog

Immunotherapy
IPO Hong KongDuality Bio
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Innovation ImmunotherapyCAR-T therapy
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
Asia-Pacific Stem CellImmunotherapy
Wistar and Accelerated Biosciences Partner to Develop Novel hTSCs Platform for Immunotherapies
2024-07-15
Trials & Approvals CAR-T therapyCAR T-cell Therapy
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
Partnerships Moderna
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Funding Immunotherapy
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Trials & Approvals Immunotherapy
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
China Immunotherapy
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
Policy FDA Guidance
FDA Drops New Oncology Development Guidelines
2022-10-18
Trials & Approvals B-cell Lymphoma
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Trials & Approvals Follicular Lymphoma
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
R&D DNA
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
Trials & Approvals CAR T-cell Therapy
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Technology CAR T-cell Therapy
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
1 2 3 … 8
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
READ MORE
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top